...
首页> 外文期刊>Physics in medicine and biology. >Range and dose verification in proton therapy using proton-induced positron emitters and recurrent neural networks (RNNs)
【24h】

Range and dose verification in proton therapy using proton-induced positron emitters and recurrent neural networks (RNNs)

机译:使用质子诱导的正电子发射器和经常性神经网络(RNNS)的质子疗法中的范围和剂量验证

获取原文
获取原文并翻译 | 示例

摘要

Online proton range/dose verification based on measurements of proton-induced positron emitters is a promising strategy for quality assurance in proton therapy. Because of the nonlinear correlation between the dose distribution and the activity distribution of positron emitters, we aim to establish their relationship using recurrent neural network models (LSTM, BiLSTM, GRU, BiGRU and Seq2seq). Simulations were carried out with a spot-scanning proton system using Geant4- 10.3 toolkit and a CT-based patient phantom. The 1D distributions of positron emitters and radiation dose were obtained. Training data were modeled for different beam energy, irradiation positions and counting statistics. The prediction accuracy of range and dose were quantitatively studied. The impact of including anatomical information (HU values in CT images) on the prediction performance was investigated. The BiGRU demonstrates the most stable and accurate performance with good capability of generalization, especially with the inclusion of anatomical information. When the signal-to-noise ratio (SNR) of the 1 D activity profiles is about 3, the range accuracy can be within 0.5 mm and the dose accuracy close to the peak region is <5% (relative uncertainty between prediction and raw input for all datasets). The feasibility of proton range and dose verification using the RNN-based framework was demonstrated. The RNN-based framework promises to provide a reliable and effective way for online monitoring, quality assurance and ultimately allows for adaptive proton therapy.
机译:基于质子诱导的正电子发光仪的测量的在线质子范围/剂量验证是质子疗法质量保证的有希望的策略。由于剂量分布与正电子发射器的活动分布之间的非线性相关性,我们的目标是使用经常性神经网络模型建立它们的关系(LSTM,Bilstm,Gru,Bigru和SEQ2Seq)。使用GEANT4-103工具包和基于CT的患者幻影,用点扫描质子系统进行模拟。获得了正电子发射器和辐射剂量的1D分布。培训数据被建模用于不同的光束能量,辐照位置和计数统计数据。定量地研究了范围和剂量的预测精度。研究了包括在预测性能上对预测性能的解剖信息(HU值)的影响。 BIGRU展示了具有良好泛化能力的最稳定和准确的性能,特别是包含解剖信息。当1 d活动轮廓的信噪比(SNR)约为3时,范围精度可以在0.5mm以内,并且靠近峰值区域的剂量精度<5%(预测和原始输入之间的相对不确定性对于所有数据集)。证实了质子范围和使用基于RNN的框架的剂量验证的可行性。基于RNN的框架承诺为在线监测,质量保证和最终提供适应性质子疗法的可靠有效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号